# Fukuzyu Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/fukuzyu-pharmaceutical-co-ltd/3877ef0e-8f5d-4826-a235-7e04748254de

> Inspection records and compliance data for Fukuzyu Pharmaceutical Co., Ltd. in Toyama, None. Access full analysis and detailed observations.

---

## Details

- Name: Fukuzyu Pharmaceutical Co., Ltd.
- FEI Number: 3002807025
- City: Toyama
- State: None
- Country Name: Japan
- Address Line 1: 48, Hagihara
- Zip Code: None

## Related Documents

- [483 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/483/fukuzyu-pharmaceutical-co-ltd/5552dead-02ee-43ee-aad8-8c303db1c886) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/1552c541-65a5-480e-a82d-3e626e7926fc) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/e878825f-e643-4f5f-b80f-b1c5a17ded54) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/93641215-c512-4196-9f47-79b91c537faa) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2025
- [FDA Inspection 1295338 - Fukuzyu Pharmaceutical Co., Ltd. - 2025-11-11](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/54bf00d2-fc48-4c9c-83e5-fe68cc3518e2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2025
- [483 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-19](https://www.keypedia.com/records/483/fukuzyu-pharmaceutical-co-ltd/66552528-7f7e-40bd-b48e-8d2fbc441945) — source: FDA, date: January 19, 2024
- [FDA Inspection 1228860 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-19](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/13d1f747-4859-46c8-bfa1-2870be8dfdc1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2024
- [FDA Inspection 1228860 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-19](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/1a568251-7ac7-43f1-9209-19a4f2acbb1a) — classification: Official Action Indicated (OAI), source: FDA, date: January 19, 2024
- [483 - Fukuzyu Pharmaceutical Co., Ltd. - 2024-01-15](https://www.keypedia.com/records/483/fukuzyu-pharmaceutical-co-ltd/7079954a-4964-4e3c-9ed4-b2b9dfd957dc) — source: FDA, date: January 15, 2024
- [FDA Inspection 980722 - Fukuzyu Pharmaceutical Co., Ltd. - 2016-07-28](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/0260f99e-5bea-462e-8fa3-71ec3afdea04) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 28, 2016
- [FDA Inspection 826382 - Fukuzyu Pharmaceutical Co., Ltd. - 2013-03-15](https://www.keypedia.com/records/fda_inspections/fukuzyu-pharmaceutical-co-ltd/3382ff37-2805-403d-ae9f-d824dcac2e22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 15, 2013

## Related Companies

- [Marcus Research Laboratory, Inc.](https://www.keypedia.com/companies/marcus-research-laboratory-inc/6ed62b27-3200-4374-b004-ec4c541dc0d9)
- [Alps Pharmaceutical Industrial Co., Ltd.](https://www.keypedia.com/companies/alps-pharmaceutical-industrial-co-ltd/b7368086-4ecc-4cbe-b942-494bb1340c79)
- [DDP Specialty Electronic Materials US 9, LLC](https://www.keypedia.com/companies/ddp-specialty-electronic-materials-us-9-llc/bfd7705b-0b03-4c4e-a3d7-d0940e04a868)
- [Kyowa Hakko Bio Co., Ltd.](https://www.keypedia.com/companies/kyowa-hakko-bio-co-ltd/4ab0756a-78b6-4060-8087-809db6e7941b)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Zhejiang Ruibang Laboratories Co., Ltd](https://www.keypedia.com/companies/zhejiang-ruibang-laboratories-co-ltd/d492de6c-b477-4077-b11f-1b6185504623)
- [Piramal Pharma Limited](https://www.keypedia.com/companies/piramal-pharma-limited/c2aa1ac8-a474-4948-84c1-cd848c50558e)
- [Morton Salt Inc](https://www.keypedia.com/companies/morton-salt-inc/823fa877-7377-4020-9234-37328296eec4)
- [BASF AS avd Sandefjord](https://www.keypedia.com/companies/basf-as-avd-sandefjord/1b76cb86-c9db-45f9-bfdd-e2eaec2a67b7)

## Related Officers

- [Senior Managing Director](https://www.keypedia.com/people/tetsuaki-nishinaga/0caddce5-a415-4f29-abab-433caf9290db)
- [Senior CSO, Investigator](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)
- [Nibin Varghese](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)